Enter your keyword(s)


Phibro Animal Health was established in December 2000, following the acquisition of the medicated feed additive business of Pfizer Animal Health. A division of Phibro Animal Health Corporation, our company develops, manufactures and markets medicated feed additives. We also market animal health and nutrition products manufactured by other Phibro Animal Health Corporation subsidiaries.

Phibro Animal Health serves customers worldwide throughout the Animal Health & Nutrition and Performance Products industries. Our 1,100 employees are proud to manufacture and market more than 550 specialty products all over the globe. Our combined annual sales are more than $650 million.

About medicated feed additives

Medicated feed additives (MFAs) are pharmaceutical products that may be added to the feedstuffs of poultry, pigs, cattle or other food-animal species. The inclusion rate for these products is extremely small — measured in grams per ton of feed — yet they have a big impact on the health and welfare of poultry and livestock. MFAs are unique because they can be delivered quickly and efficiently to a large number of animals at the same time.

Among the classes of medications found in MFAs are:

  • Antibiotics to prevent and treat bacterial diseases
  • Anticoccidials, both ionophores and chemically synthesized, to control coccidiosis
  • Dewormers to control intestinal parasites

Promise for a healthier future

Working from our strong foundation in medicated feed additives, we look forward to discovering and utilizing innovations in animal health. We will continue to explore both existing and emerging technologies that benefit livestock and poultry producers to enable us to grow our position as a global health solutions provider for the industry.

Back To Top

Our management

Larry Miller, President
Jonathan Bendheim, Vice President MACIE Region, General Manager Phibro Israel
Richard Coulter, Vice President Scientific and Regulatory Affairs
Dr. Avner Finger, Vice President Biological Operation and Development
Warren Harper, Senior Vice President Global Marketing
Alexander Hladky, Senior Vice President Quality, Sourcing and Strategic Alliance
Fred Iversen, Vice President Latin America Region
Stefan Mihailov, Vice President and General Manager Brazil
Mike Murphy, Vice President Asia Pacific Region
Jose Santos, Senior Vice President Finance
Troy Smith, Senior Vice President Global Fermentation Production and Supply

Back To Top

Our headquarters

View Larger Map


Phibro Animal Health Headquarters
Glenpointe Centre East, 3rd Fl
300 Frank W. Burr Blvd., Ste 21
Teaneck, NJ 07666-6712

Telephone: 201-329-7300
Fax: 201-329-7399

Back To Top

Our facilities

Phibro Animal Health global headquarters and North American business offices are located in Teaneck, New Jersey. Our regional offices are established in Argentina, Australia, Belgium, Brazil, Canada, China, Hong Kong, Malaysia, Mexico and South Africa. Our manufacturing facility is located in Guarulhos, Brazil.

Back To Top

Directions to Phibro Animal Health Corporation

From The George Washington Bridge
From the GWB follow signs for I-94 South/80 West Local Lanes
Exit 70, Teaneck, Glenpointe will be directly in front of you.

Back To Top

From Lincoln Tunnel and NJ Turnpike North
NJ Turnpike North to Exit 18W
Follow signs for I-95 North Local Lanes
Exit 70, follow signs for Teaneck (Exit 70B)
Exit 70, Teaneck, Glenpointe will be on your right after crossing the highway

Back To Top

From Garden State Parkway and Route 80 East
Exit 159 off the Garden State Parkway
Follow signs for Route 80 East
Stay in Local Lanes to Exit 70-Teaneck
Glenpointe will be on your right after crossing over the highway

Back To Top

From Route 4
Take the Teaneck Road/Ridgefield Park Exit
Stay on Teaneck Road to DeGraw avenue (5 traffic lights) and make a left
Glenpointe will be on your right

Back To Top

© 2009 - 2017 Phibro Animal Health Corporation.
All rights reserved.
• Employment • Home • Privacy Policy • Terms of Use •